Evidence map›Paper›PMID 29563824›Full record

ArticleClinical, cosmetic and investigational dermatology2018

In vivo validation of the multicomponent powder (Vitachelox

Luca Giacomelli, Stefano Togni, Martino Meneghin, Roberto Eggenhöffner, Giada Maramaldi

Open access · goldAbstract read
In one paragraph

Article in Clinical, cosmetic and investigational dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Luca GiacomelliDepartment of Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy.
Stefano TogniIndena S.p.A, Milan, Italy.
Martino MeneghinIndena S.p.A, Milan, Italy.
Roberto EggenhöffnerDepartment of Surgical Science and Integrated Diagnostics, University of Genoa, Genoa, Italy.
Giada MaramaldiIndena S.p.A, Milan, Italy.
Indena (Italy) · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe purpose of this in vivo study is to evaluate the acute clinical application of a multicomponent powder (Vitachelox PATIENTS AND

methodsIn this in vivo study, we evaluated the skin protective activity of the multicomponent powder formulated in a base emulsion compared to a relevant placebo cream. Using the tape stripping method, SC samples of face skin obtained from 30 healthy volunteers were compared following a 6-h exposure in a polluted area.

resultsNo statistically significant variations on the amount of heavy metals were found in the samples of SC cells obtained from the hemi-faces treated with the multicomponent powder, with respect to baseline. On the contrary, a significantly higher concentration of heavy metals was found in the cells samples obtained from the hemi-faces treated with the placebo cream. In particular, an increased concentration of heavy metals superior to 100% were found for iron and zinc (+130.2% and +142.6%, respectively;

conclusionThis in vivo study validates and extends previous in vitro findings, indicating that the multicomponent powder allows the prevention of any metal deposition within the SC following exposure in a polluted environment. Our results suggest that the test product could play an effective role in counteracting skin damages induced by air pollution.

Indexed as

air pollutionantipollutiongrape seed extractgreen tea extractheavy metalsoak wood extractoxidative stresspolyphenolsstratum corneum

Identifiers

PMID29563824
PMCPMC5846751
OpenAlexW2793005578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.